Patents by Inventor Yu-Mi Ahn

Yu-Mi Ahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ULK INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20240150368
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: August 28, 2023
    Publication date: May 9, 2024
    Inventors: Justin T. Proto, Andrew Michael Harned, Kristen Stoltz, Timothy Caldwell, Lakshminarayana Vogeti, Yu Mi Ahn, Bertrand Le Bourdonnec, Daniel L. Flynn
  • KIT KINASE INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20240116877
    Abstract: Described herein are compounds that are inhibitors of wild type and oncogenic mutant c-KIT kinase and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: December 2, 2022
    Publication date: April 11, 2024
    Inventors: Yu Mi Ahn, Timothy Caldwell, Daniel L. Flynn, Bertrand LeBourdonnec
  • GCN2 and perk kinase inhibitors and methods of use thereof
    Patent number: 11912668
    Abstract: Described herein are compounds, such as compounds represented by Formula I-R: and pharmaceutically acceptable salts, enantiomers, stereoisomers, and tautomers thereof, that are inhibitors of GCN2 kinase or PERK kinase, and methods of treating diseases, including diseases associated with GCN2 kinase or PERK kinase, with said compounds.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: February 27, 2024
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Daniel L. Flynn, Patrick Kearney, Jeffery Zwicker, Gada Al-Ani, Salim Javed, Yu Mi Ahn, Kristen Stoltz, Bertrand Le Bourdonnec
  • GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230382915
    Abstract: Described herein are compounds that are inhibitors of GCN2 kinase or PERK kinase, and methods of treating diseases, including diseases associated with GCN2 kinase or PERK kinase, with said compounds.
    Type: Application
    Filed: December 2, 2022
    Publication date: November 30, 2023
    Inventors: Yu Mi Ahn, Gada Al-Ani, Daniel L. Flynn, Salim Javed, Patrick Kearney, Bertrand LeBourdonnec, Kristen Stoltz, Jeffery Zwicker
  • RAF KINASE INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230357179
    Abstract: Described herein are compounds that are RAF inhibitors and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: December 9, 2022
    Publication date: November 9, 2023
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Lakshminarayana Vogeti, Bertrand Le Bourdonnec
  • AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230338376
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: January 11, 2023
    Publication date: October 26, 2023
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • TRANSPARENT ELECTRODE LAMINATE AND TOUCH SENSOR INCLUDING SAME
    Publication number: 20230325014
    Abstract: The present disclosure relates to a transparent electrode laminate and a touch sensor including the same, the transparent electrode laminate comprising a first metal oxide layer, a metal layer, and a second metal oxide layer which are laminated in sequence, in which high transmittance is exhibited and excellent etching property is provided by controlling the contents of metal oxides and indium oxides (In2O3) contained in the first metal oxide layer and the second metal oxide layer.
    Type: Application
    Filed: August 24, 2021
    Publication date: October 12, 2023
    Inventors: Yu-Mi AHN, Seung-Kook KIM, Keun-Tae OH
  • RAF KINASE INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230257352
    Abstract: Described herein are compounds that are RAF inhibitors and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: December 9, 2022
    Publication date: August 17, 2023
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Lakshminarayana Vogeti, Bertrand Le Bourdonnec
  • Aminopyrimidine amide autophagy inhibitors and methods of use thereof
    Patent number: 11590134
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: February 28, 2023
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230047915
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: June 3, 2022
    Publication date: February 16, 2023
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230039712
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: June 6, 2022
    Publication date: February 9, 2023
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
    Patent number: 11530206
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: December 20, 2022
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • ANTENNA STACK STRUCTURE AND DISPLAY DEVICE INCLUDING THE SAME
    Publication number: 20220393335
    Abstract: An antenna stack structure according to an embodiment includes a protective layer, and an antenna electrode layer formed directly on a surface of the protective layer. The antenna electrode layer includes a first electrode layer and a second electrode layer having a lower reflectance than that of the first electrode layer. A visual recognition of electrode are prevented by the second electrode layer.
    Type: Application
    Filed: August 10, 2022
    Publication date: December 8, 2022
    Inventors: Han Sub RYU, Yu Mi AHN, Ho Dong YOON, Won Hee LEE, Jae Hyun LEE
  • Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
    Patent number: 11518758
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: December 6, 2022
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20220274934
    Abstract: Described herein are compounds that are inhibitors of GCN2 kinase or PERK kinase, and methods of treating diseases, including diseases associated with GCN2 kinase or PERK kinase, with said compounds.
    Type: Application
    Filed: November 17, 2021
    Publication date: September 1, 2022
    Inventors: Daniel L. Flynn, Patrick Kearney, Jeffery Zwicker, Gada AI-Ani, Salim Javed, Yu Mi Ahn, Kristen Stoltz, Bertrand LeBourdonnec
  • Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
    Patent number: 11390611
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: July 19, 2022
    Assignee: Deciphera Pharmaceuticals, LLC
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20210128556
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: June 16, 2020
    Publication date: May 6, 2021
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20200354352
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: May 8, 2020
    Publication date: November 12, 2020
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20200354346
    Abstract: Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.
    Type: Application
    Filed: May 8, 2020
    Publication date: November 12, 2020
    Inventors: Daniel L. Flynn, Yu Mi Ahn, Timothy Caldwell, Lakshminarayana Vogeti
  • Metal nanowire having core-shell structure coated with graphene, and manufacturing method therefor
    Patent number: 10566104
    Abstract: The present invention relates to a method for manufacturing a nanowire of a core-shell structure including a metal nanowire core and a graphene shell, comprising the steps of: providing a metal nanowire; and coating the metal nanowire with graphene by a plasma chemical vapor deposition method. In addition, the present invention relates to: a nanowire having a core-shell structure including a metal nanowire core and a graphene shell; and a transparent electrode formed from the nanowire. The transparent electrode formed from the nanowire having a core-shell structure has advantages of having controllable copper oxidation characteristics, being optically, electrically and mechanically excellent, and enabling the transparent electrode to be manufactured at a low cost.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: February 18, 2020
    Assignee: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Youn Gu Lee, Young Jun Jeong, Yu Mi Ahn, Dong Hwa Lee